Medtox
Past Recompete Updated
- Agency
-
Indian Health Service
Department of Health and Human Services
- Solicitation expected
- Estimated value
- $10,000 to $25,000
- Set-aside
- No set-aside
Forecast facts
- Incumbent contract
-
- 75H71125F80088 Federal contract award held by Medtox Laboratories Inc. Ended Oct 22, 2025 · Value with all options $19,780
- Anticipated award
- NAICS code
- 621511 Medical Laboratories
- Points of contact
Forecast details come from HHS's procurement forecast. Agencies' dates and values are estimates.
About this forecast
The Indian Health Service is recompeting a contract for urine drug screen reagent, with solicitation release estimated for October 1, 2026, and award targeted for December 1, 2026. The procurement supports IHS healthcare and substance abuse screening programs and carries no set-aside designation.
The estimated award value ranges from $10,000 to $25,000. The incumbent contractor, Medtox Laboratories Inc. (a division of Laboratory Corporation of America Holdings), holds a GSA Multiple Award Schedule contract as the primary vehicle for delivery orders. Points of contact are Shelton Bruce, Contracting Officer (shelton.bruce@ihs.gov, 405-951-1810), and Docia Sampson, Medical Technologist (docia.sampson@ihs.gov).
The existing award being recompeted is delivery order 47QSWA20D007S-75H71125F80088, issued to Medtox Laboratories Inc. on July 24, 2025, valued at $19,779.60 for the purchase of 12 drug screening panels. The delivery order completed on October 22, 2025.
Forecast text
Urine Drug Screen Reagent
On GovTribe
Work this forecast
- Track it in your pipeline
- Find teaming partners
- Similar forecasts
- Ask GovTribe AI about this forecast